Saricaoglu Fatma, Akinci Seda B, Celiker Varol, Aypar Ulku
Department of Anesthesiology and Reanimation, Medical Faculty, Hacettepe University Sihhiye, Ankara 06100,Turkey.
Saudi Med J. 2005 May;26(5):792-8.
In this study, acute normovolemic hemodilution (ANH) and hypervolemic hemodilution (HHD) were compared with no hemodilution with regards to the effectiveness in blood usage and coagulation parameters.
The study was performed from February to August 2001 at Hacettepe University Hospital, Ankara, Turkey. Thirty patients undergoing hip arthroplasty surgery were prospectively randomized into: ANH group [autologous blood 15 mL kg(-1) was withdrawn and replaced by 6% hydroxyethylstarch (HES)] or HHD group (HES was administered without removal of any autologous blood) or the control group (no hemodilution). In all groups, blood was given when hemoglobin concentration was <9 g dl(-1).
Three groups were clinically similar regarding blood loss, mean arterial pressures and coagulation parameters. But allogeneic transfusion requirements were significantly less in hemodilution groups (20% in ANH, 40% in HHD) compared to the control group (100% of patients).
We conclude that hemodilution (both ANH and HHD) decreases the demand for homologous blood without adversely affecting hemodynamics or coagulation parameters and HHD seems to be a simple and valuable alternative to ANH in orthopedic patient undergoing hip replacement.
本研究比较急性等容血液稀释(ANH)和高容血液稀释(HHD)与不进行血液稀释在血液使用效果和凝血参数方面的差异。
该研究于2001年2月至8月在土耳其安卡拉的哈杰泰佩大学医院进行。30例行髋关节置换手术的患者被前瞻性随机分为:ANH组[抽取自体血15 mL/kg,并用6%羟乙基淀粉(HES)替代]或HHD组(输注HES而不抽取任何自体血)或对照组(不进行血液稀释)。所有组在血红蛋白浓度<9 g/dl时输血。
三组在失血量、平均动脉压和凝血参数方面临床情况相似。但与对照组(100%的患者)相比,血液稀释组的异体输血需求显著减少(ANH组为20%,HHD组为40%)。
我们得出结论,血液稀释(ANH和HHD)均可降低对同源血的需求,且不会对血流动力学或凝血参数产生不利影响,对于接受髋关节置换的骨科患者,HHD似乎是ANH的一种简单且有价值的替代方法。